NCT00951847View on ClinicalTrials.gov

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

oxcarbazepine 300 mg/5 mL oral suspension

Trial Locations (1)

Unknown

Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00951847 - Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition | Biotech Hunter | Biotech Hunter